Connors JM - Search Results

1

Long-term follow-up and analysis for prognostic factors for patients with limited-stage diffuse large-cell lymphoma treated with initial chemotherapy with or without adjuvant radiotherapy.

Jones SE, Miller TP, Connors JM. Jones SE, et al. Among authors: connors jm. J Clin Oncol. 1989 Sep;7(9):1186-91. doi: 10.1200/JCO.1989.7.9.1186. J Clin Oncol. 1989. PMID: 2671279 Clinical Trial.

2

Prognostic variables in patients with diffuse large-cell lymphoma treated with MACOP-B.

Hoskins PJ, Ng V, Spinelli JJ, Klimo P, Connors JM. Hoskins PJ, et al. Among authors: connors jm. J Clin Oncol. 1991 Feb;9(2):220-6. doi: 10.1200/JCO.1991.9.2.220. J Clin Oncol. 1991. PMID: 1703227

3

Low-dose ACOP-B and VABE: weekly chemotherapy for elderly patients with advanced-stage diffuse large-cell lymphoma.

O'Reilly SE, Klimo P, Connors JM. O'Reilly SE, et al. Among authors: connors jm. J Clin Oncol. 1991 May;9(5):741-7. doi: 10.1200/JCO.1991.9.5.741. J Clin Oncol. 1991. PMID: 1707954 Clinical Trial.

4

MACOP-B and VACOP-B in diffuse large cell lymphomas and MOPP/ABV in Hodgkin's disease.

O'Reilly SE, Hoskins P, Klimo P, Connors JM. O'Reilly SE, et al. Among authors: connors jm. Ann Oncol. 1991 Jan;2 Suppl 1:17-23. doi: 10.1093/annonc/2.suppl_1.17. Ann Oncol. 1991. PMID: 1710485 Free article.

5

Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease.

Reece DE, Barnett MJ, Connors JM, Fairey RN, Fay JW, Greer JP, Herzig GP, Herzig RH, Klingemann HG, LeMaistre CF, et al. Reece DE, et al. Among authors: connors jm. J Clin Oncol. 1991 Oct;9(10):1871-9. doi: 10.1200/JCO.1991.9.10.1871. J Clin Oncol. 1991. PMID: 1919637

6

MOPP/ABV hybrid program: combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin's disease.

Klimo P, Connors JM. Klimo P, et al. Among authors: connors jm. J Clin Oncol. 1985 Sep;3(9):1174-82. doi: 10.1200/JCO.1985.3.9.1174. J Clin Oncol. 1985. PMID: 2411881

7

Ketoconazole versus nystatin as prophylaxis against fungal infection for lymphoma patients receiving chemotherapy.

Turhan A, Connors JM, Klimo P. Turhan A, et al. Among authors: connors jm. Am J Clin Oncol. 1987 Aug;10(4):355-9. doi: 10.1097/00000421-198708000-00019. Am J Clin Oncol. 1987. PMID: 2441593 Clinical Trial.

8

Allogeneic marrow transplantation for refractory Hodgkin's disease.

Phillips GL, Reece DE, Barnett MJ, Connors JM, Fay JW, Herzig GP, Herzig RH, Klingemann HG, Shepherd JD, Wolff SN. Phillips GL, et al. Among authors: connors jm. J Clin Oncol. 1989 Aug;7(8):1039-45. doi: 10.1200/JCO.1989.7.8.1039. J Clin Oncol. 1989. PMID: 2474058

9

Brief chemotherapy and involved field radiation therapy for limited-stage, histologically aggressive lymphoma.

Connors JM, Klimo P, Fairey RN, Voss N. Connors JM, et al. Ann Intern Med. 1987 Jul;107(1):25-30. doi: 10.7326/0003-4819-107-1-25. Ann Intern Med. 1987. PMID: 3296898 Clinical Trial.

10

Testicular lymphoma: improved outcome with early brief chemotherapy.

Connors JM, Klimo P, Voss N, Fairey RN, Jackson S. Connors JM, et al. J Clin Oncol. 1988 May;6(5):776-81. doi: 10.1200/JCO.1988.6.5.776. J Clin Oncol. 1988. PMID: 3367185

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

757 results

Search Page

Filters